US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 3.5600
  • -0.1500-4.04%
Close Jun 17 16:00 ET
  • 3.4100
  • -0.1500-4.21%
Pre 09:13 ET
3.35MMarket Cap0.28P/E (TTM)

Avenue Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.32%3.71M
80.78%14.54M
-45.83%2.12M
211.92%2.07M
548.43%3.92M
124.55%6.43M
115.17%8.04M
328.01%3.91M
-23.97%663K
-36.38%605K
Selling and administrative expenses
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
-27.13%454K
-General and administrative expense
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
-27.13%454K
Research and development costs
-56.07%2.39M
284.03%10.36M
80.18%982K
367.53%907K
1,904.64%3.03M
201.16%5.45M
115.15%2.7M
39.74%545K
-30.22%194K
-53.96%151K
Operating profit
42.32%-3.71M
-80.78%-14.54M
45.83%-2.12M
-211.92%-2.07M
-548.43%-3.92M
-124.55%-6.43M
-115.17%-8.04M
-328.01%-3.91M
23.97%-663K
36.38%-605K
Net non-operating interest income expense
116.61%49K
81.93%-206K
101.92%22K
800.00%9K
5,600.00%57K
-14,850.00%-295K
-16,385.71%-1.14M
-114,500.00%-1.14M
0.00%1K
-50.00%1K
Non-operating interest income
32.43%49K
530.00%126K
37.50%22K
800.00%9K
5,600.00%57K
1,750.00%37K
185.71%20K
1,500.00%16K
0.00%1K
-50.00%1K
Non-operating interest expense
--0
-71.38%332K
--0
--0
--0
--332K
--1.16M
--1.16M
--0
--0
Other net income (expense)
21.41%-690K
-23.69%4.26M
2.71M
2.57M
-150K
-878K
5.58M
Gain on sale of security
86.79%-116K
-23.69%4.26M
--2.71M
--2.57M
---150K
---878K
--5.58M
----
----
----
Other non- operating income (expenses)
---574K
----
----
----
----
----
----
----
----
----
Income before tax
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
Income tax
Net income
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
Net income continuous Operations
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
Minority interest income
86.36%-9K
-117.65%-111K
54.90%-23K
-13K
-9K
-66K
-51K
-51K
0
0
Net income attributable to the parent company
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
36.35%-604K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
36.35%-604K
Basic earnings per share
-1,295.35%-1.16K
39.88%-73.5
-79.24%1.8752
113.33%4.5
-26.83%-39
46.16%-82.775
50.46%-122.25
116.28%9.0336
43.04%-33.75
54.44%-30.75
Diluted earnings per share
-1,295.35%-1.16K
39.88%-73.5
-79.24%1.8752
113.33%4.5
-26.83%-39
46.16%-82.775
50.46%-122.25
116.28%9.0336
43.04%-33.75
54.44%-30.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.32%3.71M80.78%14.54M-45.83%2.12M211.92%2.07M548.43%3.92M124.55%6.43M115.17%8.04M328.01%3.91M-23.97%663K-36.38%605K
Selling and administrative expenses 33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K-27.13%454K
-General and administrative expense 33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K-27.13%454K
Research and development costs -56.07%2.39M284.03%10.36M80.18%982K367.53%907K1,904.64%3.03M201.16%5.45M115.15%2.7M39.74%545K-30.22%194K-53.96%151K
Operating profit 42.32%-3.71M-80.78%-14.54M45.83%-2.12M-211.92%-2.07M-548.43%-3.92M-124.55%-6.43M-115.17%-8.04M-328.01%-3.91M23.97%-663K36.38%-605K
Net non-operating interest income expense 116.61%49K81.93%-206K101.92%22K800.00%9K5,600.00%57K-14,850.00%-295K-16,385.71%-1.14M-114,500.00%-1.14M0.00%1K-50.00%1K
Non-operating interest income 32.43%49K530.00%126K37.50%22K800.00%9K5,600.00%57K1,750.00%37K185.71%20K1,500.00%16K0.00%1K-50.00%1K
Non-operating interest expense --0-71.38%332K--0--0--0--332K--1.16M--1.16M--0--0
Other net income (expense) 21.41%-690K-23.69%4.26M2.71M2.57M-150K-878K5.58M
Gain on sale of security 86.79%-116K-23.69%4.26M--2.71M--2.57M---150K---878K--5.58M------------
Other non- operating income (expenses) ---574K------------------------------------
Income before tax 42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K
Income tax
Net income 42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K
Net income continuous Operations 42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K
Minority interest income 86.36%-9K-117.65%-111K54.90%-23K-13K-9K-66K-51K-51K00
Net income attributable to the parent company 42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K36.35%-604K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K36.35%-604K
Basic earnings per share -1,295.35%-1.16K39.88%-73.5-79.24%1.8752113.33%4.5-26.83%-3946.16%-82.77550.46%-122.25116.28%9.033643.04%-33.7554.44%-30.75
Diluted earnings per share -1,295.35%-1.16K39.88%-73.5-79.24%1.8752113.33%4.5-26.83%-3946.16%-82.77550.46%-122.25116.28%9.033643.04%-33.7554.44%-30.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg